Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revvity (RVTY)
NYSE:RVTY
Holding RVTY?
Track your performance easily
RVTY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$88.62 - $129.50
Previous Close$116.14
Volume775.55K
Average Volume (3M)820.92K
Market Cap
$14.13B
Enterprise Value$16.22B
Total Cash (Recent Filing)$1.23B
Total Debt (Recent Filing)$3.32B
Price to Earnings (P/E)47.2
Beta0.83
Next Earnings
Jan 29, 2025EPS Estimate
$1.37Next Dividend Ex-Date
Jan 17, 2025Dividend Yield0.24%
Share Statistics
EPS (TTM)2.46
Shares Outstanding121,702,145
10 Day Avg. Volume1,026,744
30 Day Avg. Volume820,922
Standard Deviation0.10
R-Squared0.33
Alpha-0.00253
Financial Highlights & Ratios
Price to Book (P/B)1.71
Price to Sales (P/S)4.91
Price to Cash Flow (P/CF)22.60
P/FCF Ratio26.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.96
Enterprise Value/Gross Profit10.53
Enterprise Value/Ebitda26.71
Forecast
1Y Price Target
$132.18Price Target Upside13.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Revvity News
Bulls Say, Bears Say
Bulls Say
ImmunoDx GrowthImmunoDx showed continued strength in the third quarter with mid-single-digit growth, where management called out strength across geographies.
Portfolio Stability And ImprovementThere are signs of stability and improvement across the portfolio, which, combined with solid cost controls, deleveraging, greater capital return, and a valuation at the midpoint of the sector, supports an attractive setup into the end of the year and 2025.
Recurring Revenue And MarginsRVTY's recently transformed portfolio of select LST assets and its attractive ~80% recurring revs profile drives its top-quartile margin (60%+ gross margins and ~30% op margins) and is poised to generate strong incremental leverage when volumes do recover.
Bears Say
Financial GuidanceThe company's revenue guidance for 2024 has been reduced due to lowered expectations for overall instrumentation performance in the fourth quarter.
Market PerformanceCustomer spending on instruments remains constrained, especially in China, which has affected the company's market performance.
Product Segment WeaknessWeaker performance in instruments, particularly in China, has significantly impacted the Applied Genomics outlook.
---
Ownership Overview
0.36% Insiders
35.13% Mutual Funds
31.80% Other Institutional Investors
9.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RVTY FAQ
What was Revvity’s price range in the past 12 months?
Revvity lowest stock price was $88.62 and its highest was $129.50 in the past 12 months.
What is Revvity’s market cap?
Currently, no data Available
When is Revvity’s upcoming earnings report date?
Revvity’s upcoming earnings report date is Jan 29, 2025 which is in 39 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Nov 04, 2024. The company reported $1.28 earnings per share for the quarter, beating the consensus estimate of $1.126 by $0.154.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity pays a Quarterly dividend of $0.07 which represents an annual dividend yield of 0.24%. See more information on Revvity dividends here
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is $1.37.
How many shares outstanding does Revvity have?
Revvity has 121,702,150 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of $1.28 in its last earnings report, beating expectations of $1.126. Following the earnings report the stock price went up 3.123%.
Which hedge fund is a major shareholder of Revvity?
Among the largest hedge funds holding Revvity’s share is EdgePoint Investment Group Inc.. It holds Revvity’s shares valued at 343M.
---
Revvity Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$132.18 (13.26% Upside)
$132.18 (13.26% Upside)
Blogger Sentiment
Bullish
RVTY Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 541.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.5%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.23%
12-Months-Change
Fundamentals
Return on Equity
3.31%
Trailing 12-Months
Asset Growth
-4.86%
Trailing 12-Months
Company Description
Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
---
RVTY Company Deck
---
RVTY Earnings Call
Q3 2024
0:00 / 0:00
---
RVTY Revenue Breakdown
53.02% Diagnostics
46.98% Life sciences
---
RVTY Stock 12 Month Forecast
Average Price Target
$132.18
▲(13.26% Upside)
Technical Analysis
Best Analysts Covering RVTY
1 Year
1 Year Success Rate
19/31 ratings generated profit
1 Year Average Return
+9.47%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.29% of your transactions generating a profit, with an average return of +9.47% per trade.
---